Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Caficrestat by Applied Therapeutics for Cardiomyopathy: Likelihood of Approval
Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Cardiomyopathy. According to GlobalData, Phase III...
Caficrestat by Applied Therapeutics for Diabetic Peripheral Neuropathy: Likelihood of Approval
Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Diabetic Peripheral Neuropathy. According to GlobalData,...
Caficrestat by Applied Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Caficrestat is under clinical development by Applied Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...
Caficrestat by Applied Therapeutics for Cardiomyopathy: Likelihood of Approval
Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Cardiomyopathy. According to GlobalData, Phase III...